The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes

International Immunology

Volumn 7, Issue 8, 1995, Pages 1295-1299

  Kern, Ilse ^a   Steimle, Viktor ^a   Siegrist, Claire anne ^a   Mach, Bernard ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

CIITA; Gene regulation; HLA class II; HLA DM; RFX5

Indexed keywords

HLA D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANTIGEN PRESENTATION; ARTICLE; GENE EXPRESSION REGULATION; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

CELL LINE; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HELA CELLS; HLA-D ANTIGENS; HUMAN; INTERFERON TYPE II; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0029132892     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/7.8.1295     Document Type: Article

References (25)

1. Kelly, A P., Monaco, J. J., Cho, S, and Trowsdale, J, 1991. A new human HLA class ll-related locus, DM. Nature 353:571.
2. Ring, S. P., Arp, B. and Pious, D. 1994. HLA-DMA and -DMB genes are both required for MHC class ll/peptide complex formation in antigen-presenting cells. Nature 368:554.
3. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J. J. and Mellins, E. (1994) An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368:551.
4. Denzin, L. K., Robbins, N. F., Carboy-Newcomb, C. and Cresswell, P. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595.
5. Griscelli, C., Lisowska-Grospierre, B. and Mach, B. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135.
6. Lisowska-Grospierre, B., Charron, D. J., de Preval, C., Durandy, A., Griscelli, C. and Mach, B. 1985. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J. Clin. Invest. 76:381.
7. de Preval, C., Lisowska-Grospierre, B., Loche, M., Griscelli, C. and Mach, B. 1985. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 318:291.
8. Mach, B., Steimle, V. and Reith, W. 1994. MHC class ll-deficient combined immunodeficiency: A disease of gene regulation. Immunol. Rev. 138:207.
9. Steimle, V., Otten, L. A., Zufferey, M. and Mach, B. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
10. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B. and Reith, W. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
11. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B. and Mach, B. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106.
12. Amaldi, I., Reith, W., Berte, C. and Mach, B. 1989. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein. J. Immunol. 142:999.
13. Kao, C. C., Lieberman, P. M., Schmidt, M. C., Zhou, Q., Pei, R. and Berk, A. J. 1990. Cloning of a transcriptionally active human Tata binding factor. Science 248:1646.
14. Chirgwin, J. M., Przbyla, A. E., MacDonald, R. J. and Rutter, J. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
15. Sambrook, J., Fritsch, E. F. and Maniatis, T. 1989. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
16. Blanar, M. A., Boettger, M. C. and Flavell, R. A. 1988. Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein. Proc. Natl Acad. Sci. USA 85:4672.
17. Celada, A., Klemsz, M. J. and Maki, R. A. 1989. Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II l-A beta, tumor necrosis factor and complement component C3 in mouse macrophages. Eur. J. Immunol. 19:1103.
18. Hume, C. R. and Lee, J. S. 1989. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol. 26:288.
19. Benichou, B. and Strominger, J. L. 1991. Class ll-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl Acad. Sci. USA 88:4285.
20. Nocera, A., Barocci, S., De Palma, R. and Gorski, J. 1993. Analysis of transcripts of genes located within the HLA-D region in B cells from an HLA-severe combined immunodeficiency individual. Hum. Immunol. 38:231.
21. Chang, C. H. and Flavell, R. A. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
22. Trowsdale, J. 1993. Genomic structure and function in the MHC. Trends Genet. 9:117.
23. Kelly, A. and Trowsdale, J. 1994. Novel genes in the human major histocompatibility complex class-ll region. Int. Arch. Allergy Immunol. 103:11.
24. Kovats, S., Drover, S., Marshall, W. H., Freed, D., Whiteley, P. A., Nepom, G. T. and Blum, J. 1994. Coordinate defects in human histocompatibility leukocyte antigen class-ll expression and antigen presentation in bare lymphocyte syndrome. J. Exp. Med. 179:2017.
25. Karlsson, L., Péléraux, A., Lindstedt, R., Liljedahl, M. and Peterson, P. A. 1994. Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. Science 266:1569.